eClinical Tech News

Camp4 Therapeutics, a clinical-stage biotech focused on RNA-targeting therapies, recently reported second-quarter financials and provided a key program update....

Outlook Therapeutics Achieves First European Sales of Lytenava™ for Wet AMD, Awaits US FDA Decision Outlook Therapeutics has commenced...

Chemomab Therapeutics, a clinical-stage biotech focused on fibro-inflammatory diseases, announced its second-quarter 2025 financial results, highlighting progress in its...

Cocrystal Pharma, a clinical-stage biotech company, has reported favorable safety and tolerability data from its Phase 1 study of...

Vyne Therapeutics, a clinical-stage biopharmaceutical company focused on inflammatory and immune-mediated conditions, reported second-quarter financials alongside a strategic pipeline...

Avicanna’s Q2 2025 results reveal a company navigating a complex cannabis market, demonstrating both progress and persistent challenges. While...

Evaxion A/S, a clinical-stage AI-driven vaccine developer, announced its second-quarter 2025 financial results, highlighting key pipeline advancements and strategic...

Lexeo Therapeutics’ recent business updates reveal a company aggressively pursuing growth and solidifying its position in the genetic medicine...

Cassava Sciences is pivoting to Tuberous Sclerosis Complex (TSC)-related epilepsy, announcing positive preclinical data for its simufilam therapy and...

Abeona Therapeutics has launched Zevaskyn, the first and only gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) wounds, marking...